Dutasteride Capsule, Liquid Filled
Product Images NDC 59651-021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 59651-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dutesteride Fig1)

FDA Label Image

Figure (Dutesteride Fig2)

FDA Label Image

Figure (Dutesteride Fig3)

FDA Label Image

Figure (Dutesteride Fig4)

FDA Label Image

Figure (Dutesteride Fig5)

FDA Label Image

Figure (Dutesteride Fig6)

FDA Label Image

Figure (Dutesteride Fig7)

FDA Label Image

Package Label-principal Display Panel (0.5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (0.5 mg (30 Tablet Bottle))
This is a medication called Dutasteride Capsules manufactured by Aurobindo Pharma USA, Inc. Each soft gelatin capsule has 0.5mg of Dutasteride USP. The usual adult dosage is one capsule per day, to be swallowed whole and not chewed or opened. The dosing information and warnings indicate that this medication should not be used by women or children and should be protected from moisture. This medication should be stored in a tight, light-resistant container at a controlled room temperature. There is also a code provided for dispensing and tracking purposes during packing.*
FDA Label Image

Chemical Structure (Dutesteride Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.